"SPEEDING SAFE AND EFFECTIVE CANCER TREATMENTS TO PATIENTS IS OUR ONLY MISSION"
Enrollment for the 2017 AAADV Workshop is open now

May 3-5, 2017

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Office of Hematology and Oncology Drug Products

U.S. Food and Drug Administration Center for Drug Evaluation and Research

Programs

14th Annual AAADV Workshop

Leaders in clinical and translational cancer research from academic, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 3-5, 2017

Enroll Now

 

Workshop 2016 Gallery

Speakers

 

AAADV Mobile app coming soon for Android and iOS

app-store-imagegoogle-play-image


Location

Twitter Feed


TWEET WITH THE HASHTAG #AAADV2016